Tfb Advisors LLC Dexcom Inc Transaction History

Tfb Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$110.31 - $140.45 $26,033 - $33,146	236 Added 10.12%	2,569 $291,000
Q1 2024 May 03, 2024	BUY	$114.22 - $140.1 $266,475 - $326,853	2,333 New	2,333 $323,000
Q2 2023 Jul 18, 2023	BUY	$112.47 - $130.98 $25,305 - $29,470	225 Added 11.21%	2,232 $286,000
Q1 2023 Apr 10, 2023	BUY	$104.0 - $122.92 $20,072 - $23,723	193 Added 10.64%	2,007 $233,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $154,153 - $222,523	1,814 New	1,814 $205,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Tfb Advisors LLC with notifications on news.